BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2938519)

  • 1. [New findings and experiences in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].
    Schröder J; Linge C; Wähner A
    Fortschr Neurol Psychiatr; 1988 Mar; 56(3):97-101. PubMed ID: 2896144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome and related conditions].
    Amore M; Montanari M
    Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroleptic malignant syndrome--a review.
    Gibb WR; Lees AJ
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
    Spiess-Kiefer C; Hippius H
    Fortschr Neurol Psychiatr; 1986 May; 54(5):158-70. PubMed ID: 2426164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts. Neuroleptic malignant syndrome.
    Guzé BH; Baxter LR
    N Engl J Med; 1985 Jul; 313(3):163-6. PubMed ID: 3892294
    [No Abstract]   [Full Text] [Related]  

  • 12. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia: the clinical syndrome.
    Ranklev-Twetman E
    Acta Anaesthesiol Belg; 1990; 41(2):79-82. PubMed ID: 2371808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The malignant neuroleptic syndrome and malignant hyperthermia].
    Mitterschiffthaler G; Hackl JM; Neumann R
    Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonneuroleptic malignant syndrome.
    Johnson SB; Alvarez WA
    J Clin Psychiatry; 1988 Feb; 49(2):79-80. PubMed ID: 3338982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant hyperthermia in swine during isoflurane anesthesia].
    Sümpelmann R; Bötel C; Zimmermann M; Krohn S; Strauss JM; Paul T
    Dtsch Tierarztl Wochenschr; 1994 May; 101(5):207-8. PubMed ID: 8013300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.